Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nicotinell Mint 4mg medicated chewing gum
0410020B0BCAGBD
|
Nicotinell | Nicotine | Central Nervous System | 123 |
|
Nicorette QuickMist SmartTrack 1mg/dose mouthspray
0410020B0BBBGBW
|
Nicorette | Nicotine | Central Nervous System | 94 |
|
Nicorette Fruit 2mg lozenges
0410020B0BBBFAY
|
Nicorette | Nicotine | Central Nervous System | 81 |
|
Nicotine 450micrograms/dose inhaler CFC free
0410020B0AACDCD
|
Nicotine | Nicotine | Central Nervous System | 56 |
|
Voke 0.45mg/dose inhaler
0410020B0BLAACD
|
Voke | Nicotine | Central Nervous System | 42 |
|
NiQuitin Pre-Quit Clear 21mg patches
0410020B0BDARAR
|
NiQuitin | Nicotine | Central Nervous System | 27 |
|
NiQuitin 4mg lozenges original menthol mint
0410020B0BDAHAZ
|
NiQuitin | Nicotine | Central Nervous System | 24 |
|
NiQuitin 2mg lozenges original menthol mint
0410020B0BDAGAY
|
NiQuitin | Nicotine | Central Nervous System | 11 |
|
NiQuitin Fresh Mint 2mg medicated chewing gum
0410020B0BDAIBA
|
NiQuitin | Nicotine | Central Nervous System | 5 |
|
Nicorette 10mg patches
0410020B0BBADAT
|
Nicorette | Nicotine | Central Nervous System | 3 |
|
NiQuitin Minis Cherry 1.5mg lozenges
0410020B0BDAQBP
|
NiQuitin | Nicotine | Central Nervous System | 3 |
|
Nicotine 6mg medicated chewing gum sugar free
0410020B0AACCCC
|
Nicotine | Nicotine | Central Nervous System | 2 |
|
Boots NicAssist Microtab 2mg sublingual tablets
0410020B0BHBAAW
|
Boots nicotine | Nicotine | Central Nervous System | 1 |
|
Nicorette 15mg patches
0410020B0BBAEAU
|
Nicorette | Nicotine | Central Nervous System | 1 |
|
NiQuitin Extra Fresh Mint 2mg medicated chewing gum
0410020B0BDAUBA
|
NiQuitin | Nicotine | Central Nervous System | 1 |
|
NiQuitin Fresh Mint 4mg medicated chewing gum
0410020B0BDAJBD
|
NiQuitin | Nicotine | Central Nervous System | 1 |
|
Boots NicAssist 10mg Inhalator
0410020B0BHANAV
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist 10mg patches
0410020B0BHALAT
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist 10mg/ml nasal spray
0410020B0BHASAN
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist 14mg/24hours transdermal patches
0410020B0BHAXAQ
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist 15mg Inhalator
0410020B0BHAUBZ
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist 15mg patches
0410020B0BHAMAU
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist 21mg/24hours transdermal patches
0410020B0BHAYAR
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist 2mg sublingual tablets
0410020B0BHAHAW
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
|
Boots NicAssist 5mg patches
0410020B0BHAKAS
|
Boots nicotine | Nicotine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.